6-K

Sofgen Pharma S.A. (PROCF)

6-K 2021-12-10 For: 2021-12-10
View Original
Added on April 06, 2026

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM6-K

REPORT OF FOREIGN PRIVATEISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGEACT OF 1934


For the month of December 2021

Commission File Number: 001-40851

ProcapsGroup, S.A.

(Translation of registrant’s name in English)


9 rue de Bitbourg, L-1273

Luxembourg

Grand Duchy of Luxembourg

R.C.S. Luxembourg: B253360

Tel : +356 7995-6138

(Address of Principal ExecutiveOffices)


Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒          Form 40-F ☐ ****

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐


Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐


Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.



INFORMATION CONTAINEDIN THIS REPORT ON FORM 6-K


Financial Results

On November 19, 2021, Procaps Group, S.A. (the “Company”) issued a press release announcing its financial results for the third quarter ended September 30, 2021. The press release was furnished as Exhibit 99.1 to a previous Current Report on Form 6-K, dated November 19, 2021. On November 23, 2021, the Company announced a correction to the Adjusted EBITDA figure in the press release, which did not reflect an adjustment for transaction expenses in the amount of $500,000. As a result of the correction, the Company’s Adjusted EBITDA for the three months ended September 30, 2021 was $25.0 million instead of the previously reported $24.5 million.

The Unaudited Condensed Consolidated Interim Financial Statements for the third quarter ended September 30, 2021 are filed as Exhibit 99.1 to this Report on Form 6-K and are incorporated by reference into the registration statement on Form F-1 filed with the Securities and Exchange Commission on November 24, 2021 (File No. 333-261366).


Exhibit Index

Exhibit Number Exhibit Title
99.1 Unaudited Condensed Consolidated Interim Financial Statements for the third quarter ended September 30, 2021.
1

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

PROCAPS GROUP, S.A.
By: /s/ Ruben Minski
Name: Ruben Minski
Title: Chief Executive Officer

Dated: December 10, 2021

2

Exhibit 99.1

Procaps Group S.A. and subsidiaries (The Group)

Unaudited Condensed Consolidated Interim Statementof Financial Position

As of September 30, 2021 and December 31, 2020

(In thousands of United States Dollars, unlessotherwise stated)

As of<br><br> September 30,<br><br> 2021 As of <br><br>December 31, <br><br>2020
Assets
Non-current assets
Property, plant and equipment, net $ 71,259 70,335
Right-of-use assets 36,645 43,195
Goodwill 6,851 6,863
Intangible assets 24,754 27,583
Investments in joint ventures 2,478 2,460
Other financial assets 440 761
Deferred tax assets 6,675 21,769
Other assets 2,778 1,870
Total non-current assets 151,880 174,836
Cash 100,192 4,229
Trade and other receivables, net 110,023 96,493
Inventories, net 76,981 64,284
Amounts owed by related parties 3,398 2,562
Current tax assets 21,314 16,774
Other current assets 960 360
Total current assets 312,868 184,702
Total assets $ 464,748 359,538
Liabilities and stockholders’ equity (deficit)
Total equity (deficit) $ 36,305 (254,678 )
Borrowings 101,932 339,738
Amounts owed to related parties 11,190 12,163
Warrant liability 33,950
Deferred tax liabilities 1,451 18,890
Other liabilities 3,173 3,797
Total non-current liabilities 151,696 374,588
Borrowings 116,713 102,621
Trade and other payables, net 132,462 106,275
Amounts owed to related parties 5,703 8,459
Current tax liabilities 14,249 9,393
Provisions 1,663 1,829
Other liabilities 5,957 11,051
Total current liabilities 276,747 239,628
Total liabilities and stockholders' equity (deficit) $ 464,748 359,538

Procaps Group S.A. and subsidiaries (The Group)

Unaudited Condensed Consolidated Interim Statementof Profit or Loss

For the three and nine months ended September30, 2021 and 2020

(In thousands of United States Dollars, unlessotherwise stated)

For the three months ended<br><br> September 30
2021 2020
Revenue $ 106,829 79,313
Cost of sales (44,577 ) (31,525 )
Gross profit 62,252 47,788
Sales and marketing expenses (22,841 ) (19,234 )
Administrative expenses (21,011 ) (14,370 )
Finance expenses (50,651 ) (14,236 )
Other expenses (1,107 ) (1,668 )
Income (loss) before tax $ (33,358 ) (1,720 )
Income tax expense (3,566 ) 751
Loss for the period $ (36,924 ) (969 )
For the nine months ended<br><br> September 30
--- --- --- --- --- --- ---
2021 2020
Revenue $ 283,206 213,320
Cost of sales (123,152 ) (90,133 )
Gross profit 160,054 123,187
Sales and marketing expenses (61,191 ) (53,352 )
Administrative expenses (64,670 ) (43,857 )
Finance expenses (79,242 ) (39,763 )
Other expenses (3,179 ) (5,406 )
Income (loss) before tax $ (48,228 ) (19,191 )
Income tax expense (6,342 ) (701 )
Loss for the period $ (54,570 ) (19,892 )
2

Procaps Group S.A. and subsidiaries (The Group)

Unaudited Condensed Consolidated Interim Statementof Cash Flows

For the nine months ended September 30, 2021and 2020

(In thousands of United States Dollars, unlessotherwise stated)

For the nine months ended<br><br> September 30
2021 2020
Operating activities
Loss for the period $ (54,570 ) $ (19,892 )
Adjustments to reconcile net loss with net cash from operating activities:
Depreciation of property, plant and equipment 4,184 4,062
Depreciation of right-of-use 3,281 3,098
Amortization of intangibles 5,892 4,705
Income tax expense 6,342 701
Finance expenses 79,242 39,763
Share of result of joint ventures (371 ) (416 )
Net (gain)/loss on sale of property, plant and equipment 710
Inventory provision 3,263 3,538
Provision for bad debt 741 (2,087 )
Provisions 1,182 1,599
Cash flow from operating activities before changes in working capital $ 49,896 $ 35,071
(Increase)/decrease in operating assets and liabilities:
Trade and other receivables (14,271 ) 20,526
Amounts owed by related parties (835 ) (7,038 )
Inventories (15,523 ) 828
Current tax assets (4,540 ) (5,295 )
Other current assets (563 ) (47 )
Trade and other payables (10,975 ) (12,772 )
Amounts owed to related parties (252 ) 9,148
Current tax liabilities (1,120 ) (3,542 )
Other liabilities 13,710 (4,534 )
Provisions (1,182 ) (2,110 )
Other financial assets 321
Other assets (946 ) (4,027 )
Cash generated from operations $ 13,720 $ 26,208
Dividends received 300
Income tax paid (2,711 ) 3,291
Cash flow from operating activities $ 11,309 $ 29,499
Investing activities
Acquisition of property, plant and equipment (10,933 ) (5,641 )
Proceeds from sale of property, plant and equipment 26
Acquisition of intangibles (5,898 ) (5,595 )
Cash flow used in investing activities $ (16,805 ) $ (11,236 )
Financing activities
Proceeds from borrowings 122,042 89,950
Payments on borrowings (80,101 ) (75,209 )
Payments to related parties (3,577 ) (4,836 )
Interest paid on borrowings (9,527 ) (7,997 )
Payment of lease liabilities (4,354 ) (3,511 )
Cash obtained from acquisition 91,585
Cash flow generated from (used in) financing activities $ 116,068 $ (1,603 )
Net increase/(decrease) in cash 110,572 16,660
Cash less bank overdrafts at beginning of the period 4,229 2,042
Effect of exchange rate fluctuations (14,609 ) (12,229 )
Cash less bank overdrafts at end of the period $ 100,192 $ 6,473
Non-cash financing and investing activities (1) $ 948 $ 6,418
3

Procaps Group S.A. and subsidiaries (The Group)

Unaudited Condensed Consolidated Interim Statementof Changes in Equity

For the nine months ended September 30, 2021and 2020

(In thousands of United States Dollars, unless otherwise stated)

Attributable<br> to equity holders of the Group
Issued<br><br> Capital Share<br><br> premium Reserves ^1^ Accumulated<br><br> deficit Other<br><br> Comprehensive<br><br> Income Total Non-<br><br>controlling<br><br> interest Total<br><br> equity<br><br> (deficit)
Balance<br> as of December 31, 2019 2,001 54,412 28,681 (305,634 ) (23,753 ) (244,293 ) 346 (243,947 )
Loss<br> for the period (20,620 ) (20,620 ) 728 (19,892 )
Transfer<br> reserves 11,177 (11,177 )
Other<br> comprehensive income 11,600 11,600 11,600
Non-controlling<br> interest 728 728 728
Balance<br> as of September 30, 2020 $ 2,001 $ 54,412 $ 39,858 $ (336,703 ) $ (12,153 ) $ (252,585 ) $ 1,074 $ (251,511 )
Balance<br> as of December 31, 2020 2,001 54,412 39,897 (327,344 ) (24,421 ) (255,455 ) 778 (254,677 )
Loss<br> for the period (54,947 ) (54,947 ) 377 (54,570 )
Transfer<br> reserves (8 ) 8
Other<br> comprehensive income (3,894 ) (3,894 ) (3,894 )
Non-controlling<br> interest 377 377 377
Share<br> redemption and issuance in business combination (873 ) 201,304 148,638 349,069 349,069
Balance<br> as of September 30, 2021 $ 1,128 $ 255,716 $ 39,889 $ (233,268 ) $ (28,315 ) $ 35,150 $ 1,155 $ 36,305
^1^ Includes the appropriate values from net income to comply with<br>legal provisions related to asset protection according to applicable jurisdictions with cumulative earnings.
--- ---

4